Fraunhofer Institute for Cell Therapy and Immunology IZIAccelerating the Development of Cell and Gene Therapies
To accelerate the transition of new cell and gene therapies from research to clinical application, Otto von Guericke University Magdeburg, Magdeburg University Hospital, and the Fraunhofer Institute for Cell Therapy and Immunology IZI have entered into a strategic partnership.
Fraunhofer IZI brings to the partnership its experience in application-oriented research in the field of cell and gene therapies, as well as its long-standing expertise in the GMP-compliant manufacture of innovative therapeutics. The institutions are already closely linked through Prof. Dr. Stephan Fricke, Director of Clinical Transfer at Fraunhofer IZI, who has held the Chair of Clinical Immunology and Cell Therapeutics at Magdeburg University Hospital since October 2025 and heads the Institute for Clinical Immunology and Cell Therapeutics at the University of Magdeburg.